Dimethylamine

Dimethylamine

SCHEMBL4746686

CNC.NC1CC1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclohexylamine SCHEMBL4239622 0.86 THRB (0.39)
Ethane SCHEMBL2240892 0.80
Methylamine SCHEMBL27815781 0.80 THRB (0.36)
Methylamine SCHEMBL15877924 0.80
SCHEMBL5547 0.80
SCHEMBL28183717 0.78
Methyl Alcohol SCHEMBL27333250 0.76
SCHEMBL8339261 0.75
SCHEMBL65642 0.75
SCHEMBL84592 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100522809-C ITQ-31 crystalline solid and its manufacturing method INST FRANCAIS DU PETROLE (FR) 2009-08-05 CN claimed
US-7025948-B2 ITQ-31 crystalline solid, and a process for its preparation INSTITUT FRANCAIS DU PETROLE (FR) 2006-04-11 US claimed
CN-1721324-A ITQ-31 crystalline solid and its manufacturing method INST FRANCAIS DU PETROLE (FR) 2006-01-18 CN claimed
US-20050244330-A1 ITQ-31 crystalline solid, and a process for its preparation INSTITUT FRANCAIS DU PETROLE (FR) 2005-11-03 US claimed
WO-2024149303-A1 STEROID-CATIONIC LIPID COMPOUND AND USE THEREOF 辽宁键凯科技有限公司 2024-07-18 WO disclosed
CN-118324841-A Steroid-cationic lipid compound and application thereof 辽宁键凯科技有限公司 2024-07-12 CN disclosed
EP-3313829-B1 LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS ACUITAS THERAPEUTICS INC (CA) 2024-04-10 EP disclosed
US-20230372537-A1 LIPID NANOPARTICLE FORMULATIONS ACUITAS THERAPEUTICS INC (CA) 2023-11-23 US disclosed
US-11712481-B2 Lipid nanoparticle formulations Acuitas Therapeutics, Inc. (CA) 2023-08-01 US disclosed
US-20220226461-A1 Nucleoside-modified RNA for Inducing an Adaptive Immune Response THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 2022-07-21 US disclosed
US-20220204439-A1 LIPIDS AND LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS ACUITAS THERAPEUTICS INC (CA) 2022-06-30 US disclosed
CN-114085198-A Lipid and lipid nanoparticle formulations for delivery of nucleic acids 爱康泰生治疗公司 2022-02-25 CN disclosed
US-7025948-B2 ITQ-31 crystalline solid, and a process for its preparation INSTITUT FRANCAIS DU PETROLE (FR) 2006-04-11 US disclosed
CN-1721324-A ITQ-31 crystalline solid and its manufacturing method INST FRANCAIS DU PETROLE (FR) 2006-01-18 CN disclosed
US-20050244330-A1 ITQ-31 crystalline solid, and a process for its preparation INSTITUT FRANCAIS DU PETROLE (FR) 2005-11-03 US disclosed
US-6348599-B1 CYANINE DYES HAVING OVERALL POSITIVE CHARGE OF +2 TO +6 AND REACTIVE OR FUNCTIONAL GROUP PRESENT WHICH CAN REACT WITH FUNCTIONAL OR REACTIVE GROUP OF TARGET MOLECULE NYCOMED AMERSHAM PLC (GB) 2002-02-19 US disclosed
US-5242609-A Dispersants and oxidation resistance SHELL OIL COMPANY (US) 1993-09-07 US disclosed
EP-0437880-A1 Lubricating oil compositions and their preparation SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1991-07-24 EP disclosed
US-4325885-A Method for preparation of oligomeric iminic derivatives of aluminum ANIC S.P.A. (IT) 1982-04-20 US disclosed
US-4239692-A Oligomeric iminic derivatives of aluminum hydride and method for their preparation ANIC S.P.A. (IT) 1980-12-16 US disclosed